Tuesday, November 29, 2022
Advertisement

France: Enalees opens first subsidiary in the UK

French animal diagnostic specialist, Enalees,  has marked the start of its European expansion plans with the opening of its first subsidiary in North Yorkshire...

Sweden: ADDvise Group places SEK150m of bonds

ADDvise, a supplier of equipment to healthcare and research facilities, has placed SEK150m (US$14.5m) of senior secured bonds, launched off its existing senior secured...

InFocus: ePharmacy —  different markets, different models

Community pharmacy, also known as retail pharmacy, is the most common type of pharmacy and gives the public access to medication and advice regarding...

Spain: Cofinimmo to build new nursing and care home in Granada

Brussels listed real estate investor, Cofinimmo, intends to build a new nursing and care home in Maracena, near Granada (Spain) at a cost of...

Financing round-up: FundaMental Pharma, Deep Optics, YonaLink, Cradle, CatalYm

Germany: FundaMental Pharma, a preclinical neuroscience company spun out of Heidelberg University, has raised a €10m (US$10m) Seed investment, co-led by BioGeneration Ventures (BGV)...

Ireland: Uniphar supplements European distribution network with BModesto acquisition

International diversified healthcare services business, Uniphar, has acquired BModesto Group, a Netherlands headquartered healthcare services business focused on improving access to pharmaceutical and healthcare...

Spain: Unavets Group raises €116m from Ares Management

The Unavets Group, a leading veterinary healthcare group with more than 90 practices across Spain and Portugal, has raised an additional €116m (US$119m) from...

Israel: Francis to take up CEO role at Teva in January

Teva Pharmaceutical Industries has appointed Richard Francis as president and CEO, effective January 1, 2023. He replaces Kåre Schultz who will retire effective December...

Sweden: Chordate Medical plans rights issue to see it through next year

Nasdaq First North listed Chordate Medical plans to carry out an issue of shares with preferential rights amounting to approximately SEK51.3m (US$4.8m) The rights issue is...

Norway: GE Healthcare increases API capacity

GE Healthcare’s Pharmaceutical Diagnostics business is investing US$80m to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) site in Lindesnes,...